Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors

Online download statistics by month:

Online download statistics by month: October 2022 to September 2024

	Abstract	Full	Pdf
Oct 2022	654	691	167
Nov 2022	284	293	121
Dec 2022	150	155	64
Jan 2023	158	164	55
Feb 2023	117	119	45
Mar 2023	87	90	33
Apr 2023	49	53	29
May 2023	69	71	30
Jun 2023	45	45	17
Jul 2023	40	43	19
Aug 2023	60	64	28
Sep 2023	58	60	25
Oct 2023	28	30	16
Nov 2023	61	65	31
Dec 2023	50	51	21
Jan 2024	52	54	24
Feb 2024	54	57	28
Mar 2024	51	51	63
Apr 2024	58	58	30
May 2024	60	61	31
Jun 2024	59	59	32
Jul 2024	65	67	26
Aug 2024	65	67	43
Sep 2024	54	54	20
Total	2428	2522	998